Cubist Systematic Strategies’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $26.2M | Buy |
206,642
+64,722
| +46% | +$7.7M | 0.13% | 197 |
|
|
2025
Q2 | $17.4M | Buy |
141,920
+103,419
| +269% | +$11.8M | 0.08% | 346 |
|
|
2025
Q1 | $3.9M | Sell |
38,501
-18,714
| -33% | -$1.83M | 0.02% | 1033 |
|
|
2024
Q4 | $5.28M | Buy |
+57,215
| New | +$5.62M | 0.03% | 804 |
|
|
2024
Q3 | – | Sell |
-83,347
| Closed | -$7.15M | – | 3114 |
|
|
2024
Q2 | $7.15M | Buy |
83,347
+73,683
| +762% | +$6.18M | 0.05% | 576 |
|
|
2024
Q1 | $798K | Buy |
9,664
+8,694
| +896% | +$637K | ﹤0.01% | 2337 |
|
|
2023
Q4 | $64.7K | Sell |
970
-12,309
| -93% | -$797K | ﹤0.01% | 3243 |
|
|
2023
Q3 | $892K | Sell |
13,279
-3,733
| -22% | -$257K | 0.01% | 1968 |
|
|
2023
Q2 | $1.15M | Sell |
17,012
-167,927
| -91% | -$10.5M | 0.01% | 1867 |
|
|
2023
Q1 | $10M | Buy |
184,939
+160,745
| +664% | +$9.36M | 0.06% | 455 |
|
|
2022
Q4 | $1.45M | Buy |
24,194
+22,220
| +1,126% | +$1.21M | 0.01% | 2124 |
|
|
2022
Q3 | $89K | Sell |
1,974
-126,995
| -98% | -$6.35M | ﹤0.01% | 4046 |
|
|
2022
Q2 | $5.75M | Buy |
128,969
+105,834
| +457% | +$5.43M | 0.04% | 862 |
|
|
2022
Q1 | $1.31M | Sell |
23,135
-54,531
| -70% | -$2.85M | 0.01% | 1820 |
|
|
2021
Q4 | $4.03M | Sell |
77,666
-80,111
| -51% | -$4.13M | 0.04% | 807 |
|
|
2021
Q3 | $9.42M | Buy |
157,777
+51,361
| +48% | +$3.23M | 0.12% | 205 |
|
|
2021
Q2 | $6.61M | Buy |
106,416
+54,346
| +104% | +$3.62M | 0.07% | 389 |
|
|
2021
Q1 | $3.39M | Buy |
52,070
+34,961
| +204% | +$2.28M | 0.04% | 670 |
|
|
2020
Q4 | $1.13M | Buy |
17,109
+11,830
| +224% | +$696K | 0.02% | 1311 |
|
|
2020
Q3 | $273K | Sell |
5,279
-86,578
| -94% | -$4.44M | ﹤0.01% | 2020 |
|
|
2020
Q2 | $4.53M | Buy |
91,857
+64,101
| +231% | +$3.46M | 0.08% | 397 |
|
|
2020
Q1 | $1.41M | Sell |
27,756
-140,140
| -83% | -$8.08M | 0.04% | 633 |
|
|
2019
Q4 | $9.25M | Buy |
167,896
+163,535
| +3,750% | +$8.87M | 0.17% | 118 |
|
|
2019
Q3 | $220K | Sell |
4,361
-133,816
| -97% | -$6.72M | ﹤0.01% | 1728 |
|
|
2019
Q2 | $6.96M | Buy |
138,177
+8,259
| +6% | +$401K | 0.13% | 199 |
|
|
2019
Q1 | $6.04M | Buy |
129,918
+69,383
| +115% | +$3.51M | 0.2% | 90 |
|
|
2018
Q4 | $2.97M | Buy |
60,535
+33,909
| +127% | +$1.93M | 0.14% | 148 |
|
|
2018
Q3 | $1.65M | Buy |
26,626
+13,871
| +109% | +$843K | 0.09% | 282 |
|
|
2018
Q2 | $687K | Buy |
12,755
+3,048
| +31% | +$152K | 0.03% | 645 |
|
|
2018
Q1 | $441K | Sell |
9,707
-7,769
| -44% | -$333K | 0.03% | 887 |
|
|
2017
Q4 | $687K | Sell |
17,476
-1,164
| -6% | -$44.3K | 0.04% | 695 |
|
|
2017
Q3 | $687K | Buy |
+18,640
| New | +$664K | 0.04% | 627 |
|
|
2017
Q2 | – | Sell |
-11,945
| Closed | -$407K | – | 1723 |
|
|
2017
Q1 | $407K | Sell |
11,945
-6,210
| -34% | -$204K | 0.03% | 753 |
|
|
2016
Q4 | $596K | Buy |
18,155
+9,465
| +109% | +$307K | 0.05% | 583 |
|
|
2016
Q3 | $280K | Buy |
8,690
+328
| +4% | +$10.6K | 0.02% | 1049 |
|
|
2016
Q2 | $258K | Buy |
+8,362
| New | +$262K | 0.02% | 1169 |
|
|
2015
Q3 | – | Sell |
-11,132
| Closed | -$408K | – | 1889 |
|
|
2015
Q2 | $408K | Buy |
+11,132
| New | +$397K | 0.02% | 1055 |
|
|
2015
Q1 | – | Sell |
-66,287
| Closed | -$2.03M | – | 1935 |
|
|
2014
Q4 | $2.03M | Buy |
+66,287
| New | +$2.07M | 0.11% | 235 |
|
Other funds holding EHC
Cubist Systematic Strategies's EHC Position: Q3 2025 in Review
Cubist Systematic Strategies increased its Encompass Health (EHC) stake by 46% in Q3 2025, buying an estimated $7.7M and bringing the position to 206,642 shares worth $26.2M. The position accounts for 0.13% of the portfolio, ranked #197.
Cubist Systematic Strategies first reported a position in EHC in Q4 2014 and has held it in 38 quarters since. 604 funds tracked by Wall St. Rank hold EHC as of Q3 2025.
- Cubist Systematic Strategies held 206,642 shares of Encompass Health worth $26.2M as of Q3 2025.
- Cubist Systematic Strategies bought 64,722 Encompass Health shares in Q3 2025, an estimated $7.7M.
- Encompass Health made up 0.13% of Cubist Systematic Strategies's portfolio in Q3 2025, its #197 holding.
- Cubist Systematic Strategies first reported a position in Encompass Health in Q4 2014 and has held it in 38 quarters since.
- 604 funds tracked by Wall St. Rank held Encompass Health as of Q3 2025.
Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.